Publication Date:
2017-02-16
Description:
The aim of this study was to determine whether checkpoint kinase 1 inihibitor (CHK1), LY2603618, and gemcitabine prolong overall survival (OS) compared to gemcitabine alone in patients with unresectable pancre...
Electronic ISSN:
1471-2407
Topics:
Medicine
Permalink